|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| C12Q 1/6813 | |||
| C12Q 1/6883 |
| (11) | Number of the document | 3330383 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17194587.6 |
| Date of filing the European patent application | 2009-10-13 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 106491 P | 2008-10-17 | US |
| (72) |
HARLEY, Calvin, B., US
ELIAS, Laurence, US
SMITH, Jennifer, US
RATAIN, Mark J., US
BENEDETTI, Fabio, US
|
| (73) |
Geron Corporation,
919 E. Hillsdale Blvd., Foster City, CA 94404,
US
|
| (54) | GRN163L FOR USE AS TELOMERASE INHIBITOR IN THE TREATMENT OF CANCER |
| GRN163L FOR USE AS TELOMERASE INHIBITOR IN THE TREATMENT OF CANCER |